Reporter

The study found that increasing number of steps taken each day can steps taken daily can reduce the risk of several common, chronic diseases. (istock image)
October 10, 2022

Counting steps can reduce disease risk: study

A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases.

By Bill Snyder
October 10, 2022

Opening a window to glaucoma

A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.

By Bill Snyder
October 6, 2022

Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

Vanderbilt’s James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.

By Bill Snyder
October 6, 2022

Gene tied to childhood epilepsy

Data drawn from four unrelated patients with a childhood epilepsy syndrome — and from in vitro and in vivo studies — link novel variants in a GABA transporter gene to seizure activity, Vanderbilt researchers reported.

By Paul Govern
October 6, 2022

Gregory inducted into Tennessee Health Care Hall of Fame

Vanderbilt’s David Gregory, MD, associate professor of Medicine, emeritus, is among five honorees who will be inducted Oct. 18 to the Tennessee Health Care Hall of Fame.

By Paul Govern
October 6, 2022

Stress, obesity and food intake

Vanderbilt researchers are elucidating the neuronal pathways that contribute to food consumption in response to stress — “comfort feeding” — and how they differ in males versus females and in the context of obesity.

By Kelsey Pinckard
October 6, 2022

Study finds that reducing intake of simple sugars improves GERD

A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.
By Leigh MacMillan
October 6, 2022

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.
By Bill Snyder
October 6, 2022

Audio recordings could benefit older adults following clinic visits

Vanderbilt researchers are studying the impact of sharing audio recordings of their visits with older adults who have diabetes.
By Craig Boerner
October 6, 2022

Flulapalooza

Nearly 10,000 faculty, staff, postdoc scholars and students were vaccinated at last week’s Flulapalooza event.
By VUMC News and Communications
October 6, 2022

Kidney diseases research collaboration renewed

Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
By Nancy Humphrey
October 6, 2022

VWCH adds epilepsy monitoring unit, onsite neurologist

Vanderbilt Wilson County Hospital has added an epilepsy monitoring unit (EMU), with a neurologist onsite seeing patients in the hospital.
By Craig Boerner
October 6, 2022

Heart Walk

The money is still rolling in, but so far last Saturday’s Greater Nashville Heart Walk has raised more than $1.6 million in its fight against heart disease and stroke as well as provide funding for public and professional education and community service programs.
By VUMC News and Communications
1 … 67 68 69 70 71 … 725